ATE348807T1 - Schwefelsäure mono-(3- (ä1-(2-(4-fluoro-phenyl)- ethyl)-piperidin-4-ylü -hydroxy-methyl)-2-methoxy-phenyl)ester - Google Patents
Schwefelsäure mono-(3- (ä1-(2-(4-fluoro-phenyl)- ethyl)-piperidin-4-ylü -hydroxy-methyl)-2-methoxy-phenyl)esterInfo
- Publication number
- ATE348807T1 ATE348807T1 AT00947304T AT00947304T ATE348807T1 AT E348807 T1 ATE348807 T1 AT E348807T1 AT 00947304 T AT00947304 T AT 00947304T AT 00947304 T AT00947304 T AT 00947304T AT E348807 T1 ATE348807 T1 AT E348807T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- ylü
- piperidine
- fluoro
- methoxy
- Prior art date
Links
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 title 2
- 150000002148 esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35470499A | 1999-07-16 | 1999-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348807T1 true ATE348807T1 (de) | 2007-01-15 |
Family
ID=23394565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00947304T ATE348807T1 (de) | 1999-07-16 | 2000-07-13 | Schwefelsäure mono-(3- (ä1-(2-(4-fluoro-phenyl)- ethyl)-piperidin-4-ylü -hydroxy-methyl)-2-methoxy-phenyl)ester |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1202967B1 (de) |
| JP (1) | JP2003505374A (de) |
| KR (1) | KR100737718B1 (de) |
| AR (1) | AR024762A1 (de) |
| AT (1) | ATE348807T1 (de) |
| AU (1) | AU769484B2 (de) |
| BR (1) | BR0012477A (de) |
| CA (1) | CA2374635C (de) |
| CY (1) | CY1107658T1 (de) |
| DE (1) | DE60032489T2 (de) |
| DK (1) | DK1202967T3 (de) |
| ES (1) | ES2276688T3 (de) |
| HU (1) | HUP0202297A3 (de) |
| IL (2) | IL147310A0 (de) |
| MX (1) | MXPA02000444A (de) |
| NO (1) | NO324177B1 (de) |
| NZ (1) | NZ516286A (de) |
| PL (1) | PL353749A1 (de) |
| PT (1) | PT1202967E (de) |
| WO (1) | WO2001005764A2 (de) |
| ZA (1) | ZA200200101B (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169096A (en) * | 1985-07-02 | 1992-12-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl-piperidine-methanol derivatives |
| AU652759B2 (en) * | 1990-06-01 | 1994-09-08 | Aventisub Ii Inc. | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol |
| US5618824A (en) * | 1994-03-09 | 1997-04-08 | Merrell Pharmaceuticals Inc. | Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
-
2000
- 2000-07-13 IL IL14731000A patent/IL147310A0/xx active IP Right Grant
- 2000-07-13 PT PT00947304T patent/PT1202967E/pt unknown
- 2000-07-13 KR KR1020027000670A patent/KR100737718B1/ko not_active Expired - Fee Related
- 2000-07-13 ES ES00947304T patent/ES2276688T3/es not_active Expired - Lifetime
- 2000-07-13 MX MXPA02000444A patent/MXPA02000444A/es active IP Right Grant
- 2000-07-13 CA CA002374635A patent/CA2374635C/en not_active Expired - Fee Related
- 2000-07-13 NZ NZ516286A patent/NZ516286A/xx unknown
- 2000-07-13 HU HU0202297A patent/HUP0202297A3/hu unknown
- 2000-07-13 WO PCT/US2000/019065 patent/WO2001005764A2/en not_active Ceased
- 2000-07-13 AU AU60939/00A patent/AU769484B2/en not_active Ceased
- 2000-07-13 DE DE60032489T patent/DE60032489T2/de not_active Expired - Fee Related
- 2000-07-13 AT AT00947304T patent/ATE348807T1/de not_active IP Right Cessation
- 2000-07-13 PL PL00353749A patent/PL353749A1/xx not_active Application Discontinuation
- 2000-07-13 EP EP00947304A patent/EP1202967B1/de not_active Expired - Lifetime
- 2000-07-13 JP JP2001511425A patent/JP2003505374A/ja active Pending
- 2000-07-13 DK DK00947304T patent/DK1202967T3/da active
- 2000-07-13 BR BR0012477-0A patent/BR0012477A/pt not_active Application Discontinuation
- 2000-07-17 AR ARP000103646A patent/AR024762A1/es not_active Application Discontinuation
-
2001
- 2001-12-25 IL IL147310A patent/IL147310A/en not_active IP Right Cessation
-
2002
- 2002-01-04 ZA ZA200200101A patent/ZA200200101B/xx unknown
- 2002-01-15 NO NO20020213A patent/NO324177B1/no not_active IP Right Cessation
-
2007
- 2007-02-13 CY CY20071100192T patent/CY1107658T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20020213L (no) | 2002-02-22 |
| CA2374635A1 (en) | 2001-01-25 |
| HUP0202297A2 (en) | 2002-10-28 |
| NZ516286A (en) | 2004-03-26 |
| ZA200200101B (en) | 2003-06-25 |
| JP2003505374A (ja) | 2003-02-12 |
| CA2374635C (en) | 2007-04-17 |
| IL147310A (en) | 2007-10-31 |
| NO20020213D0 (no) | 2002-01-15 |
| AR024762A1 (es) | 2002-10-23 |
| DK1202967T3 (da) | 2007-04-10 |
| BR0012477A (pt) | 2002-04-02 |
| AU769484B2 (en) | 2004-01-29 |
| DE60032489T2 (de) | 2007-10-11 |
| PT1202967E (pt) | 2007-02-28 |
| WO2001005764A3 (en) | 2001-10-04 |
| KR20020042619A (ko) | 2002-06-05 |
| AU6093900A (en) | 2001-02-05 |
| HUP0202297A3 (en) | 2010-01-28 |
| ES2276688T3 (es) | 2007-07-01 |
| EP1202967A2 (de) | 2002-05-08 |
| PL353749A1 (en) | 2003-12-01 |
| DE60032489D1 (de) | 2007-02-01 |
| EP1202967B1 (de) | 2006-12-20 |
| MXPA02000444A (es) | 2002-07-02 |
| WO2001005764A2 (en) | 2001-01-25 |
| KR100737718B1 (ko) | 2007-07-11 |
| IL147310A0 (en) | 2002-08-14 |
| NO324177B1 (no) | 2007-09-03 |
| CY1107658T1 (el) | 2013-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE269861T1 (de) | Substituierte indolalkansäure | |
| NO20014849L (no) | <alfa>-substituerte karboksylsyrederivater | |
| ID22095A (id) | Asam aril-akrilat ester | |
| NO20000877D0 (no) | Forbedret syrekorrosjonsinhibitor | |
| NO20006114D0 (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat III | |
| FI20002767L (fi) | Jodoniumsuolat latentteina happodonoreina | |
| ATE239005T1 (de) | (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden | |
| NO20006115D0 (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat (I) | |
| DK1100769T3 (da) | Aminomethylcarboxylsyrederivater | |
| IS6408A (is) | Nýjar amínóprópýlfosfínsýrur | |
| ATE419231T1 (de) | Mono-substituierte 3-propyl-gamma- aminobuttersäure | |
| DE60004477D1 (de) | Verbesserter spannungspegelumsetzer | |
| ID29149A (id) | Komposisi adjuvan | |
| DE60043730D1 (de) | Arylsulfonamid-substituierte hydroxamsäure-derivate | |
| IS6400A (is) | Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra | |
| NO20016272L (no) | Substituerte fenoksyeddiksyrer | |
| ID24964A (id) | Bentuk-bentuk baru psendopolimorf dari asam dihidroklorida 2-[2-[4-[bis (4-fluorofenil) metil]-1-piperazinil) etoksi asetat | |
| ATE525362T1 (de) | 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4- | |
| ID25518A (id) | Tenunan pita ritsleting | |
| ATE242761T1 (de) | Phenyl-methoxyimino-glyoxylsäureester-derivate als pestizide | |
| NO20020213D0 (no) | Svovelsyre mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin- 4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester | |
| DE60024760D1 (de) | Einlagerungsverbindung | |
| SI1202967T1 (sl) | Mono-(3-(1-(2-(4-fluoro-fenil)-etil)-piperidin-4-il)-hidroksi-metil)-2- metoksi-fenil)ester zveplove kisline | |
| DE59906760D1 (de) | Abtaster-steuereinrichtung | |
| UA34022A (uk) | Спосіб підвищення висоти прикусу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1202967 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |